Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-OPC-17013719Phase 4Recruiting
Phase 4, open-label, single-arm trial of fluticasone, sponsored by Children's Hospital of Chongqing Medical University. Primary endpoints: Adverse events and Serious adverse events. Started Nov 2016; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-OPC-17013719.